RecruitingNCT01730092

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

A Natural History Study of Novel Biomarkers in Pulmonary Arterial Hypertension


Sponsor

National Institutes of Health Clinical Center (CC)

Enrollment

270 participants

Start Date

Jul 15, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

Background: \- High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a rare disorder. Some people have disease-associated PAH and some have PAH from an unknown cause. Researchers want to follow the natural history of all PAH patients to understand how PAH progresses in order to discover targets for future research into new treatments. To further identify treatment targets, they will compare healthy volunteers to patients with PAH. Objectives: \- To study the natural history of PAH. Eligibility: * Individuals at least 18 years of age who have PAH. * Healthy volunteers at least 18 years of age. Design: * Participants with PAH will have periodic visits to the National Institutes of Health Clinical Center. After the first visit, they will return in 6 months and then yearly or every other year for as long as the study continues. * The first visit will take up to 3 days. It will involve the following tests: * Physical exam and medical history * Blood and urine samples * Heart and lung function tests and imaging studies * Six-minute walk test * Questions about exercise and physical activity * Healthy volunteers will have only one visit to the Clinical Center, during which they will undergo screening tests, and complete many of the same tests as patients with PAH


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study tracks changes in blood markers (called biomarkers) in people with pulmonary arterial hypertension (PAH) — dangerously high blood pressure in the lungs — to better understand how the disease develops and progresses. Healthy volunteers are also enrolled as a comparison group. **You may be eligible if...** - You have been diagnosed with or are suspected to have pulmonary arterial hypertension (PAH) - You are 18 or older and able to provide written consent - Healthy adults of the matching age and sex are also eligible as controls **You may NOT be eligible if...** - You are pregnant or breastfeeding - You are under 18 - You are unable to give written consent - Healthy volunteers may be excluded if they smoke, have heart disease risk factors, obesity (BMI over 30), kidney problems, anemia, certain medications, or a history of drug use (other than marijuana more than 3 months ago) - You have a pacemaker or certain metal implants that prevent MRI scanning Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01730092


Related Trials